financetom
CIB
financetom
/
Financials
/
CIB
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Bancolombia S.A.CIB
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Bancolombia S.A. provides banking products and services in Colombia, Panama, Puerto Rico, El Salvador, Bermuda, and Guatemala.

The company operates through nine segments: Banking Colombia, Banking Panama, Banking El Salvador, Banking Guatemala, Trust, Investment Banking, Brokerage, International Banking, and All Other.

It offers checking and savings accounts, fixed term deposits, and investment products; trade financing, loans funded by domestic development banks, working capital loans, credit cards, personal and vehicle loans, payroll loans, and overdrafts; factoring; and financial and operating leasing services.

The company also provides hedging instruments, including futures, forwards, options, and swaps; and brokerage, investment advisory, and private banking services, including selling and distributing equities, futures, foreign currencies, fixed income securities, mutual funds, and structured products.

In addition, it offers cash management services; foreign currency transaction services; life, auto, commercial, and homeowner's insurance products; telephone and mobile phone banking services; and online and computer banking services.

Further, the company provides project and acquisition finance, loan syndication, corporate loans, debt and equity capital markets, principal investments, M&A, hedging strategies, restructurings, and structured financing; money market accounts, mutual and pension funds, private equity funds, payment and corporate trust, and custody; internet-based trading platform; inter-bank lending and repurchase agreements; managing escrow accounts, and investment and real estate funds; and transportation, securities brokerage, maintenance and remodeling, and outsourcing services, as well as provides technology services.

Bancolombia S.A. was founded in 1875 and is headquartered in Medellín, Colombia.

Latest News >
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Structure Therapeutics' obesity drug meets main goal in mid-stage study
Jun 3, 2024
June 3 (Reuters) - Structure Therapeutics ( GPCR ) said on Monday its obesity drug candidate met the main goal in a mid-stage study. (Reporting by Mariam Sunny in Bengaluru; Editing by Devika Syamnath) ...
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Update: Generation Mining Applauds International Energy Forum Report Outlining EV Copper Hurdles
Jun 3, 2024
07:37 AM EDT, 06/03/2024 (MT Newswires) -- Generation Mining ( GENMF ) on Monday cheered a recent report by the International Energy Forum outlining rising global demand for copper amid the energy transition. The report, titled Copper Mining and Vehicle Electrification, found that the world will not be able to produce enough copper to transition to 100% electric vehicle production...
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Science Applications International Fiscal Q1 Adjusted Earnings, Revenue Decline; Fiscal 2025 Guidance Reiterated
Jun 3, 2024
07:40 AM EDT, 06/03/2024 (MT Newswires) -- Science Applications International ( SAIC ) reported fiscal Q1 adjusted earnings Monday of $1.92 per diluted share, down from $2.14 a year earlier. Analysts polled by Capital IQ expected $1.92. Revenue for the fiscal quarter ended May 3 was $1.85 billion, down from $2.03 billion a year earlier. Analysts surveyed by Capital IQ...
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Market Chatter: Blackstone Considering Sale of Alinamin Pharmaceutical
Jun 3, 2024
07:32 AM EDT, 06/03/2024 (MT Newswires) -- Blackstone (BX) is exploring the sale of Alinamin Pharmaceutical Co., a Japanese consumer healthcare firm previously owned by Takeda Pharmaceutical Co. for around 300 billion yen ($1.9 billion), Bloomberg reported on Monday, citing people familiar with the situation. Interest in Alinamin has been expressed by investment firms such as CVC Capital Partners Plc,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved